Join
Live feed
·
INSIDERFilingvia Quantisnow
Design Therapeutics Inc. logo

Director William Arsani sold $3,463,214 worth of shares (814,874 units at $4.25) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DSGN· Design Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DSGN (Design Therapeutics Inc.) and more on Quantisnow.